Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hyperlipidemias: new data and new concepts].

E Bruckert1, P Giral, G Turpin

  • 1Service d'Endocrinologie-Métabolisme, Hôpital Pitié-Salpêtrière, 83, boulevard de l'Hôpital, F75651 Paris. eric.bruckert@psl.ap-hop-paris.fr

Presse Medicale (Paris, France : 1983)
|March 7, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Hypercholesterolemia, from screening to treatment: Who, why and how to manage].

La Revue de medecine interne·2020
Same author

Psychological predictors of the combined adoption of physical exercise and dietary change among adults with hypercholesterolemia.

Revue d'epidemiologie et de sante publique·2018
Same author

Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
Same author

[Statin treatment must be personalized].

La Revue de medecine interne·2018
Same author

[Familial hypercholesterolemia: A largely underestimated cardiovascular risk].

Annales de cardiologie et d'angeiologie·2017
Same author

Consensus statement on the management of dyslipidaemias in adults.

Annales d'endocrinologie·2017
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Statins have evolved for hyperlipidemia management, but questions remain about their pleiotropic effects and broader application. Further research is needed on triglycerides and diet

Area of Science:

  • Cardiovascular disease
  • Pharmacology
  • Lipid metabolism

Context:

  • Management of hyperlipidemia has evolved with statin therapy.
  • Statin benefits have been extended to primary and secondary prevention in various patient groups.
  • Current healthcare focuses on evidence-based medicine and cost-effectiveness.

Purpose:

  • To explore the potential pleiotropic effects of statins beyond cholesterol reduction.
  • To assess the applicability of statin benefits to underrepresented populations (women, elderly) and stroke prevention.
  • To investigate the role of triglycerides and dietary interventions in cardiovascular health.

Summary:

  • Statins are widely used for hyperlipidemia, but their cardiovascular benefits might stem from pleiotropic effects.

Related Experiment Videos

  • Further studies are needed to confirm statin efficacy in diverse populations and for stroke prevention.
  • The role of triglycerides and challenges in dietary compliance require attention.

    • Impact:

    • Advances understanding of statin mechanisms and their limitations.
    • Informs clinical practice regarding statin use in broader patient groups.
    • Highlights the importance of considering triglycerides and lifestyle modifications in cardiovascular disease management.